Remodeling tumor immunosuppressive microenvironment via a novel bioactive nanovaccines potentiates the efficacy of cancer immunotherapy

Xiaoxue Xie; Yi Feng; Hanxi Zhang; Qingqing Su; Ting Song; Geng Yang; Ningxi Li; Xiaodan Wei; Tingting Li; Xiang Qin; Shun Li; Chunhui Wu; Xiaojuan Zhang; Guixue Wang; Yiyao Liu; Hong Yang

doi:10.1016/j.bioactmat.2022.03.008

JOURNAL ARTICLE

Remodeling tumor immunosuppressive microenvironment via a novel bioactive nanovaccines potentiates the efficacy of cancer immunotherapy

Xiaoxue Xie Yi Feng Hanxi Zhang Qingqing Su Ting Song Geng Yang Ningxi Li Xiaodan Wei Tingting Li Xiang Qin Shun Li Chunhui Wu Xiaojuan Zhang Guixue Wang Yiyao Liu Hong Yang

Year: 2022 Journal: Bioactive Materials Vol: 16 Pages: 107-119 Publisher: Elsevier BV

DOI: 10.1016/j.bioactmat.2022.03.008

Get Full-Text PDF Get Analytical Report

Keywords:

Tumor microenvironment Cancer research Cancer immunotherapy Ovalbumin Immunotherapy Antigen Chemistry Immune system Antigen presentation T cell Immunology Biology

Metrics

Cited By

6.14

FWCI (Field Weighted Citation Impact)

Refs

0.96

Citation Normalized Percentile

Is in top 1%

Is in top 10%

Citation History

Topics

Immune cells in cancer

Life Sciences → Immunology and Microbiology → Immunology

Cancer Immunotherapy and Biomarkers

Health Sciences → Medicine → Oncology

Immunotherapy and Immune Responses

Life Sciences → Immunology and Microbiology → Immunology

Remodeling tumor immunosuppressive microenvironment via a novel bioactive nanovaccines potentiates the efficacy of cancer immunotherapy

Metrics

Citation History

Topics

Related Documents

Mannosylated Fluoropolypeptide Nanovaccines Remodeling Tumor Immunosuppressive Microenvironment to Achieve Highly Potent Cancer Immunotherapy

Nanovaccines for remodeling the suppressive tumor microenvironment: New horizons in cancer immunotherapy

Nanovaccines for remodeling the suppressive tumor microenvironment: New horizons in cancer immunotherapy

Cancer immunotherapy: Targeting immunosuppressive tumor microenvironment

In situ carrier-free nanovaccines reversing the immunosuppressive microenvironment for boosting tumor immunotherapy